Author

Susumu Hijioka

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center - Cited by 4,599 - Interventional EUS - EUS-FNA - pancreas - biliary - neuroendocrine tumor

Biography

Dr. Susumu  Hijioka is currently working in Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
T Ito, T Masui, I Komoto, R Doi, RY Osamura, A Sakurai, M Ikeda, ...Journal of gastroenterology 56 (11), 1033-1044, 2021202
38
2021
Cytokeratin-positive malignant tumor in the abdomen with EWSR1/FUS-CREB fusion: a clinicopathologic study of 8 cases
T Shibayama, T Shimoi, T Mori, E Noguchi, Y Honma, S Hijioka, ...The American journal of surgical pathology 46 (1), 134-146, 2022202
16
2022
Needle tract seeding after endoscopic ultrasound‐guided tissue acquisition of pancreatic tumors: Nationwide survey in Japan
M Kitano, M Yoshida, R Ashida, E Kita, A Katanuma, T Itoi, R Mikata, ...Digestive Endoscopy 34 (7), 1442-1455, 2022202
8
2022
8
2022
Fine‐needle biopsy with 19G needle is effective in combination with endoscopic ultrasound‐guided tissue acquisition for genomic profiling of unresectable pancreatic cancer
G Ikeda, S Hijioka, Y Nagashio, Y Maruki, A Ohba, Y Hisada, M Yoshinari, ...Digestive Endoscopy 35 (1), 124-133, 2023202
7
2023
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis …
Y Hisada, S Hijioka, G Ikeda, K Maehara, T Hashimoto, H Kitamura, ...Journal of Gastroenterology 7 (12), 990-998, 2022202
5
2022
Long‐term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open‐label extension study
T Ito, N Fujimori, Y Honma, A Kudo, S Hijioka, S Katsushima, Y Kimura, ...Asia‐Pacific Journal of Clinical Oncology 17 (), e13-e161, 2021202
5
2021
Usefulness of the laser‐cut, fully covered, self‐expandable metallic stent for endoscopic ultrasound‐guided hepaticogastrostomy
S Harai, S Hijioka, Y Nagashio, A Ohba, Y Maruki, M Sone, Y Saito, ...Journal of Hepato‐Biliary‐Pancreatic Sciences 29 (9), 103-1043, 2022202
5
2022
Clinical characteristics of pancreatic and biliary tract cancers associated with Lynch syndrome
S Takamizawa, C Morizane, N Tanabe, Y Maruki, S Kondo, S Hijioka, ...Journal of Hepato‐Biliary‐Pancreatic Sciences 29 (3), 377-384, 2022202
5
2022
Use of endoscopic ultrasound‐guided biliary drainage as a rescue of re‐intervention after the placement of multiple metallic stents for malignant hilar biliary obstruction
H Kitamura, S Hijioka, Y Nagashio, S Sugawara, S Nara, M Sone, M Esaki, ...Journal of Hepato‐Biliary‐Pancreatic Sciences 29 (), 404-414, 2022202
3
2022
Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients
J Tanaka, T Nakagawa, K Harada, C Morizane, H Tanaka, S Shiba, ...Scientific Reports 13 (1), 3039, 030
2
2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
Phase trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancersC Yoo, MM Javle, HV Mata, F de Braud, J Trojan, JL Raoul, JW Kim, ...Hepatology, 10.1097, 030
2
2023
Clinical utility of circulating tumor DNA in advanced rare cancers
HS Okuma, K Yonemori, Y Kojima, M Tanioka, K Sudo, E Noguchi, ...Frontiers in Oncology 11, 7355, 010
2
2021
Fine-needle biopsies with 19-gauge needle are effective combination modalities of EUS-tissue acquisition for genomic profiling of unresectable pancreatic cancer.
Fine-needle biopsies with 9-gauge needle are effective combination modalities of EUS-tissue acquisition for genomic profiling of unresectable pancreatic cancer.G Ikeda, S Hijioka, Y Nagashio, Y Maruki, A Ohba, Y Hisada, M Yoshinari, ...Digestive Endoscopy: Official Journal of the Japan Gastroenterological …, 2022202
1
2022
Novel endoscopic ultrasound-guided hepaticoduodenostomy using a forward-viewing echoendoscope for altered anatomy
Y Hisada, S Hijioka, A Ohba, Y Nagashio, Y Kanai, T Okusaka, Y SaitoEndoscopy 53 (09), E340-E342, 20220
1
2021
A novel triple stenting in the treatment of post-choledochojejunostomy reflux cholangitis
K Maehara, S Hijioka, Y Kawasaki, K Tamada, T Okusaka, Y SaitoEndoscopy 55 (S 0), E9-E93, 2023202
1
2023
The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan
S Yamamoto, N Sakakibara, H Hirano, C Morizane, Y Honma, S Hijioka, ...Scientific Reports 2 (), 760, 2022202
1
2022
A novel endoscopic technique using fully covered self-expandable metallic stents for benign strictures after hepaticojejunostomy: the saddle-cross technique (with video)
Y Kawasaki, S Hijioka, Y Nagashio, A Ohba, Y Maruki, K Maehara, ...Surgical Endoscopy 36 (2), 900-900, 2022202
1
2022